The Growing Problem of Cardiometabolic Disorders in an Ever-Shrinking World
1Atlanta Vascular Research Foundation, Emory University School of Medicine, Atlanta, GA 30084, USA
2Department of Clinical Pharmacology, Technical University, Dresden, Germany
3Hyperlipidemia Prevention Clinic, Department of Cardiology, Sir Ganga Ram Hospital, New Delhi 110060, India
4Department of Nutrition/Nursing, University of Prince Edward Island, Charlottetown, PE, Canada C1A 4P3
The Growing Problem of Cardiometabolic Disorders in an Ever-Shrinking World
Description
Recent advances in biology and medicine have introduced new therapies in treating cardiovascular diseases such as atherosclerosis and metabolic disorders (including diabetes mellitus, dyslipidemia, and hypertension). Knowledge and understanding of these conditions have led to the development of successful therapies to characterize these clinical conditions and provide better care to patients. Though there has been a positive benefit in treatment outcomes, there is an alarming trend that lifestyle changes are reversing the success of these outcomes, threatening to increase morbidity and mortality in the very near future. Moreover, this problem is rapidly becoming global, as both industrialized and developing nations are observing similar health issues of a varying degree.
We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the molecular and clinical pathology underlying cardiometabolic diseases. We are particularly interested in articles describing the new modalities for clinical characterization of cardiometabolic disorders from treatment trials in various ethnic populations throughout the world; advances in molecular genetics and molecular diagnostics; new insights into the molecular pathology of cardiometabolic disorders using animal models; current and future concepts in the prevention and management of cardiometabolic disorders. Potential topics include, but are not limited to:
- Recent developments in the epidemiology of cardiometabolic diseases in international populations
- Advances in genetics in the study of these populations
- Latest technologies for clinical evaluation and measuring outcomes
- Role of inflammation and insulin resistance in the pathology of these cardiometabolic disorders
- Cardiometabolic disease mechanism using animal model systems
- Recent advances in drug delivery
Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/crp/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: